Stjepko Pleština

机构：University Hospital Centre Zagreb, University of Zagreb

发表论文 145 篇 · 总被引 763 次 · h-index 14

代表论文

• DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols (2021 · British Journal of Clinical Pharmacology · 被引 16)
• Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy (2023 · Cancers · 被引 15)
• DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand? (2023 · Pharmacogenomics · 被引 15)
• Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions (2021 · Public Health Genomics · 被引 10)
• The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence (2022 · Medicine · 被引 7)
• The First Wave of the COVID-19 Pandemic and Its Impact on the Level of Distress in Patients with Breast Cancer, a Multicentric Study. (2021 · PubMed · 被引 5)